Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

Researchers developed cSMRTS, an engineered mRNA that preferentially turns on therapeutic genes inside targeted cells, shown ...

Mount Sinai researchers developed a first-in-class cell-selective modRNA translation system that turns therapeutic genes on only in target cells.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...

From smartphones to artificial intelligence, technology moved from the margins of daily life to its center, transforming how ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...